Lab
Community Health Clinical Laboratory LLC
Community Health Clinical Laboratory LLC was paid $11.33M by Medicaid between Aug 2020 and Dec 2024, across 78 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 9.8% of everything it billed.
33Billing provider infoCOMMUNITY HEALTH CLINICAL LABORATORY LLC
NIPOMO, CA 93444
NIPOMO, CA 93444
33aNPI1679109995assigned 03/18/2020
33bProvider typeClinical Medical Laboratory
28Total paid$11.33M
24GClaims882,875
24DCodes billed78
24AFirst – last monthAug 2020 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#66 of 561
Median peer was paid$222K
This provider vs. median51×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 64,321 | $814K | |
| 2021 | 178,215 | $2.19M | |
| 2022 | 186,911 | $2.41M | |
| 2023 | 209,630 | $2.74M | |
| 2024incomplete | 243,798 | $3.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9.8% | 40,559 | 38,505 | $1.11M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9.8% | 40,643 | 38,589 | $1.11M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 7.6% | 41,915 | 41,277 | $856K |
| 84443 | Thyroid stimulating hormone (TSH) | 7.0% | 66,916 | 66,075 | $794K |
| 80061 | Lipid panel | 6.2% | 77,244 | 76,583 | $707K |
| 80053 | Comprehensive metabolic panel | 5.7% | 88,940 | 87,596 | $643K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 5.2% | 31,053 | 29,895 | $585K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 4.8% | 19,612 | 18,883 | $544K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.5% | 11,167 | 10,137 | $509K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.2% | 86,604 | 83,656 | $477K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.0% | 65,390 | 64,165 | $449K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3.2% | 13,197 | 12,942 | $358K |
66 more codes
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2.9% | 8,837 | $328K |
| 86803 | 2.3% | 23,550 | $265K | |
| 87481 | 2.1% | 8,893 | $238K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2.1% | 8,708 | $233K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.5% | 2,947 | $169K |
| 84439 | 1.3% | 23,380 | $146K | |
| 87340 | 1.2% | 17,522 | $141K | |
| 82607 | 1.1% | 12,796 | $125K | |
| 86762 | <1% | 8,890 | $101K | |
| 84403 | <1% | 4,139 | $79K | |
| 82746 | <1% | 8,095 | $78K | |
| 82728 | <1% | 7,008 | $68K | |
| 84153 | <1% | 5,458 | $66K | |
| 86708 | <1% | 6,493 | $61K | |
| 86780 | <1% | 5,683 | $60K | |
| 82043 | <1% | 14,810 | $50K | |
| 86709 | <1% | 5,522 | $47K | |
| 80074 | <1% | 1,349 | $47K | |
| 83550 | <1% | 7,490 | $46K | |
| 87625 | <1% | 1,391 | $45K | |
| 83001 | <1% | 3,040 | $44K | |
| 82570 | <1% | 14,123 | $42K | |
| 83540 | <1% | 8,910 | $40K | |
| 86706 | <1% | 4,787 | $39K | |
| 86704 | <1% | 4,033 | $38K | |
| 80320 | <1% | 3,120 | $37K | |
| 85027 | <1% | 7,660 | $36K | |
| 84480 | <1% | 3,772 | $34K | |
| 83970 | <1% | 1,538 | $34K | |
| 82670 | <1% | 1,557 | $34K | |
| 83002 | <1% | 2,257 | $33K | |
| 84481 | <1% | 2,963 | $32K | |
| 84146 | <1% | 2,138 | $32K | |
| 86705 | <1% | 3,328 | $30K | |
| 84270 | <1% | 1,590 | $26K | |
| 84702 | <1% | 1,843 | $22K | |
| 86140 | <1% | 6,224 | $22K | |
| 82947 | <1% | 6,945 | $21K | |
| 83735 | <1% | 4,349 | $18K | |
| 84436 | <1% | 4,010 | $18K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,506 | $17K |
| 84144 | <1% | 931 | $15K | |
| 80069 | <1% | 3,110 | $14K | |
| 80076 | <1% | 2,285 | $13K | |
| 82627 | <1% | 706 | $12K | |
| 83690 | <1% | 2,411 | $12K | |
| 84154 | <1% | 1,097 | $11K | |
| 82951 | <1% | 853 | $9K | |
| 86376 | <1% | 788 | $8K | |
| 84460 | <1% | 1,720 | $6K | |
| 84550 | <1% | 2,066 | $6K | |
| 84450 | <1% | 1,480 | $5K | |
| 87522 | Neg quan hep c or qual rna | <1% | 176 | $5K |
| 85046 | <1% | 1,460 | $5K | |
| 82952 | <1% | 841 | $5K | |
| 86769 | <1% | 240 | $5K | |
| 82150 | <1% | 927 | $4K | |
| 84100 | <1% | 1,036 | $3K | |
| 85018 | <1% | 983 | $2K | |
| 85014 | <1% | 892 | $2K | |
| 83880 | <1% | 58 | $2K | |
| 82248 | <1% | 447 | $2K | |
| 82310 | <1% | 337 | $1K | |
| 81025 | <1% | 55 | $398.50 | |
| 84156 | <1% | 69 | $105.84 | |
| 82247 | <1% | 13 | $39.95 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFEOKTISTOV, ALEXANDRE (PRESIDENT)